MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM
Report
- Report Number
- 9710014-2008-00309
- Event Type
- Malfunction
- Date Received
- September 30, 2008
- Date of Event
- May 1, 2008
- Report Date
- September 17, 2008
- Manufacturer
- MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
- Product Code
- MCM
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- US
- Reporter Occupation
- OTHER
Narratives
THE DEVICE HAS NOT BEEN EXPLANTED. IF IT SHOULD BE, IT IS TO BE RETURNED TO THE MANUFACTURER FOR EVALUATION. WHEN AVAILABLE, A DEVICE ANALYSIS WILL BE SUBMITTED AS A FOLLOW-UP REPORT.
IT WAS REPORTED THAT IN (B) (6) 2008, THE PATIENT BEGAN TO EXPERIENCE HEADACHES WITH A CONSTANT 'CAR HONKING'. THE HEADACHES APPEAR TO ORIGINATE IN THE CENTER OF HER HEAD, WITH THE TINNITUS IN HER IMPLANTED EAR. SHE SEEMS TO HAVE THE SYMPTOMS WITH AND WITHOUT HER PROCESSOR. WEARING THE PROCESSOR EXACERBATES HER TINNITUS. THE PATIENT IS A DEAF ADULT WHO COMMUNICATES VIA SIGN, SO IT IS DIFFICULT TO GAUGE ANY CHANGES IN HER PERFORMANCE. THE PATIENT'S PHYSICIAN REFERRED HER BACK TO AUDIOLOGY FOR FOLLOW-UP OF HER COMPLAINTS. THE AUDIOLOGY DEPT CHANGED OUT HER EXTERNALS, BUT WITH NO CHANGE. NOW IT WAS REPORTED THAT ATTEMPT WAS MADE CREATING A PROGRAM MAP WITH ALL MCL LEVELS SET TO A MINIMUM, HOWEVER, THE PATIENT IMMEDIATELY REPORTED PAIN OVER THE IMPLANT SITE WHILE WEARING THE PROCESSOR. PER THE PATIENT, SHE WORE HER PROCESSOR CONSISTENTLY UNTIL (B) (6), THEN SHE COULD NO LONGER TOLERATE WEARING IT. A CT SCAN WAS COMPLETED, EVERYTHING WAS WITHIN NORMAL LIMITS. AIDED THRESHOLDS TODAY WERE AROUND 30 DB HL WITH A SPEECH RECOGNITION THRESHOLD OF 25 DB HL. ALL CHANNELS WERE OK AND WITHIN NORMAL LIMITS. DUE TO PATIENT COMPLAINTS AND HER INABILITY TO WEAR THE PROCESSOR, THE CLINIC HAS DECIDED TO PURSUE REVISION.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | MED-EL COMBI 40+ COCHLEAR IMPLANT SYSTEM | COCHLEAR IMPLANT | MCM | MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH | C40+ |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 29 YR |